遺伝子編集市場 – 2029年までの世界予測

Report Overview

The gene editing market is expected to reach USD 7.59 billion in 2029 from USD 4.66 billion in 2024, at a CAGR of 10.2% during the forecast period.

遺伝子編集市場は、2024年の46億6,000万米ドルから2029年には75億9,000万米ドルに達し、予測期間中のCAGRは10.2%になると予想されています。

Factors such as advancements in gene editing technologies, and the expanding range of gene editing applications are driving the growth of the gene editing market. However, the market faces several challenges due to off-target effects of gene editing, along with difficulties in scalability and manufacturing, pose significant hurdles.

“The product segment accounted for the largest share by offerings segment in the gene editing market in 2023”

By offerings, the gene editing market is segmented into products and services. The products segment held the largest share in 2023. The demand for products in gene editing process including experimentation and research for cell line development and drug development & discovery make them an indispensable part of the gene market. Gene editing products as reagents & consumables and Software & systems like gene editing kits, gene editing reagents and gene editing libraries are utilized by pharmaceutican & biotechnology companies and academic & research institutes in various gene editing workflow. Services held the second highest share of the gene editing market in 2023.

“The CRISPR technology held the highest market share of the gene editing products market by technology in 2023”

By Technology, the gene editing products market is segmented into CRISPR, TALEN, ZFN, Base editing, Antisense, RNAi and other technologies which include piggybac and prime editing among others. The CRISPR segment held the highest share of the gene editing products by technology market in 2023 driven by advancements in CRISPR technology leading to large scale adoption of this technology in gene editing. Gene editing products are used in a large range of CRISPR applications including reagents like Cas-9, vectors, libraries for screening and target identification and CRISPR based gene editing kits. Still, TALEN segment held the second largest share of the market in 2023.

“The Asia Pacific region is growing at the highest CAGR in the gene editing market from 2024 to 2029.”

The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the a significant focus on R&D activities, funding by government and private players in gene editing research, and rising adoption of gene editing technologies in drug discovery & development. Further, the rising prevalence of rare and genetic diseases is attributed to the aging population of countries such as Japan, and China. This is supporting the adoption of gene editing technologies in healthcare management and treatment driving the market growth. However, North America held the largest share of gene editing market in 2023.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers – 45% CXOs and Director-level – 30%, and Executives – 25%,
• By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5%, and Middle East -5%.

List of Companies Profiled in the Report:

• Thermo fisher scientific Inc. (US)
• Merck KGaA (Germany)
• GenScript (US)
• Agilent Technologies, Inc. (US)
• Revvity (US)
• Lonza (US)
• Tecan Trading AG (Switzerland)
• Sangamo therapeutics (US)
• Precision BioSciences (US)
• Cellectis S.A. (France)
• Regeneron Pharmaceuticals Inc. (US)
• AMSBIO (UK)
• Creative Biogene (US)
• Synthego (US)
• Takara Bio Inc. (Japan)
• Bio-Techne (US)
• Caribou Biosciences, Inc. (US)
• Bioneer corporation (South Korea)
• REPROCELL Inc. (Japan)

Research Coverage:

This research report categorizes the gene editing market by offerings (products and services), products by type (reagnets & consumables, and software & systems), reagents & consumables by Technique (knock-out, knock-in, gene silencing, and other techniques), products by technology (CRISPR, TALEN, ZFN, Base editing, Antisense, RNAi and other technologies), products by application (cell line engineering, genome editing/genetic engineering, drug discovery & development, and other applications), products by end user (pharmaceutical & biotechnology companies, academic & research institutes, CROs & CDMOs, and other end users), services by type (cell line engineering, gRNA synthesis & vector construction, library construction & screening, and other types), services by application (cell line development & engineering, genome editing/genetic engineering, drug discovery & development, and other applications), services by end user (pharmaceutical & biotechnology companies, academic & research institutes, and other end users) and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the genomics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product & service portfolio, key strategies such as product &  service launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the gene editing market. Competitive analysis of top players and upcoming startups in the gene editing market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall gene editing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Increasing demand for personalized medicine, Favorable government funding investments for gene editing projects, Expanding applications of gene editing), restraints (Off-Target Effects and Safety Concerns), opportunities (Technological advancements in Prime editing and bridge RNA, Rising burden of congenital disorders), and challenges (Issues with scalability of gene editing workflows. High equipment and facility costs) influencing the growth of the market.

• Product Development/Innovation: Detailed insights on newly launched product/services of the gene editing market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the gene editing market
• Competitive Assessment: Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), GenScript (US), Agilent Technologies, Inc. (US), Revvity (US), Lonza (US), Tecan Trading AG (Switzerland), Sangamo therapeutics (US). Precision BioSciences (US), Cellectis S.A. (France), Regeneron Pharmaceuticals Inc. (US), AMSBIO (UK), Creative Biogene (US), Synthego (US), Takara Bio Inc. (Japan), Bio-Techne (US), Caribou Biosciences, Inc. (US) Bioneer corporation (South Korea), and REPROCELL Inc. (Japan).

Table of Contents

1               INTRODUCTION              43

1.1           STUDY OBJECTIVES       43

1.2           MARKET DEFINITION   43

1.3           STUDY SCOPE   44

1.3.1        MARKETS COVERED       44

1.3.2        INCLUSIONS & EXCLUSIONS       45

1.3.3        YEARS CONSIDERED      46

1.3.4        CURRENCY CONSIDERED            46

1.4           LIMITATIONS    46

1.5           STAKEHOLDERS               46

1.6           SUMMARY OF CHANGES               47

2               RESEARCH METHODOLOGY       48

2.1           RESEARCH DATA              48

2.1.1        SECONDARY DATA          49

2.1.2        PRIMARY DATA 50

2.2           MARKET ESTIMATION METHODOLOGY               51

2.2.1        MARKET ESTIMATION  51

2.2.1.1    Insights of primary experts 53

2.2.2        SEGMENTAL MARKET SIZE ESTIMATIONS            54

2.3           MARKET GROWTH RATE PROJECTIONS                55

2.4           MARKET BREAKDOWN AND DATA TRIANGULATION                 57

2.5           RESEARCH ASSUMPTIONS           58

2.6           RESEARCH LIMITATIONS             58

2.7           RISK ANALYSIS  59

3               EXECUTIVE SUMMARY  60

4               PREMIUM INSIGHTS       66

4.1           GENE EDITING MARKET OVERVIEW       66

4.2           NORTH AMERICA: GENE EDITING MARKET, BY TYPE AND COUNTRY (2023)    67

4.3           GENE EDITING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              67

5               MARKET OVERVIEW       68

5.1           INTRODUCTION              68

5.2           MARKET DYNAMICS       68

5.2.1        DRIVERS               69

5.2.1.1    Increasing demand for personalized medicine 69

5.2.1.2    Favorable government funding investments for gene editing projects  71

5.2.1.3    Expanding applications of gene editing             72

5.2.2        RESTRAINTS      72

5.2.2.1    Off-target effects and safety concerns               72

5.2.3        OPPORTUNITIES              73

5.2.3.1    Rising technological advancements in prime editing and bridge RNA        73

5.2.3.2    Increasing burden of congenital disorders       73

5.2.4        CHALLENGES    74

5.2.4.1    Issues associated with scalability of gene editing workflows                 74

5.2.4.2    High equipment & manufacturing costs           74

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       75

5.4           PRICING ANALYSIS          76

5.4.1        AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY CONSUMABLE (2023)      76

5.4.2        AVERAGE COST RANGE OF GENE EDITING KITS & REAGENTS, 2021−2023   77

5.4.3        AVERAGE SELLING PRICE TREND OF SERVICES, BY TYPE                 78

5.4.4        AVERAGE SELLING PRICE, BY REGION   79

5.5           SUPPLY CHAIN ANALYSIS             81

5.6           VALUE CHAIN ANALYSIS               82

5.7           ECOSYSTEM ANALYSIS  86

5.8           IMPACT OF GENERATIVE AI ON GENE EDITING MARKET               87

5.9           TECHNOLOGY ANALYSIS             89

5.9.1        KEY TECHNOLOGIES     89

5.9.1.1    Next-generation sequencing               89

5.9.1.2    Electroporation     89

5.9.1.3    Microinjection       89

5.9.2        COMPLEMENTARY TECHNOLOGIES       90

5.9.2.1    Synthetic biology  90

5.9.2.2    Data analysis         90

5.9.2.3    High-throughput screening                 91

5.9.3        ADJACENT TECHNOLOGIES       91

5.9.3.1    Single-cell analysis                91

5.9.3.2    Optogenetics         92

5.9.3.3    Gene delivery systems         92

5.10         PATENT ANALYSIS          92

5.11         KEY CONFERENCES AND EVENTS, 2024−2025      94

5.12         REGULATORY ANALYSIS               95

5.12.1      REGULATORY LANDSCAPE         95

5.12.1.1  North America      96

5.12.1.1.1                US           96

5.12.1.1.2                Canada   96

5.12.1.2  Europe   97

5.12.1.2.1                UK          97

5.12.1.3  Asia Pacific            98

5.12.1.3.1                China      98

5.12.1.3.2                Japan      98

5.12.1.3.3                South Korea           98

5.12.1.3.4                Australia 99

5.12.1.3.5                Rest of Asia Pacific               99

5.12.2      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             100

5.13         PORTER’S FIVE FORCES ANALYSIS           102

5.13.1      THREAT OF NEW ENTRANTS      103

5.13.2      THREAT OF SUBSTITUTES          103

5.13.3      BARGAINING POWER OF BUYERS             103

5.13.4      BARGAINING POWER OF SUPPLIERS       103

5.13.5      INTENSITY OF COMPETITIVE RIVALRY 104

5.14         KEY STAKEHOLDERS AND BUYING CRITERIA     104

5.14.1      KEY STAKEHOLDERS IN BUYING PROCESS           104

5.14.2      KEY BUYING CRITERIA  105

5.15         CASE STUDY ANALYSIS 105

5.15.1      ENHANCED GENE KNOCK-IN EFFICIENCY USING HYBRID SSDNA HDR TEMPLATES IN PRIMARY HUMAN T-CELLS                 105

5.15.2      GENE EDITING EFFICIENCY IN CANCER CELL LINES AND T-CELLS USING TRUECUT CAS9 PROTEIN V2 AND TRUEGUIDE SGRNA        106

5.15.3      DEVELOPMENT & SPECIFICITY OPTIMIZATION OF PUREDIT CRISPR CAS9 RNP SYSTEM       106

5.15.4      EVALUATION OF SUREGUIDE CAS9 PROGRAMMABLE NUCLEASE KIT FOR EFFICIENT IN VITRO GENE EDITING                 106

5.15.5      GENE EDITING FOR SICKLE-CELL DISEASE USING ZINC FINGER NUCLEASE-MODIFIED HEMATOPOIETIC STEM CELLS                 107

5.16         INVESTMENT & FUNDING SCENARIO     107

5.16.1      KEY INVESTMENTS & FUNDING ACTIVITIES, 2021−2024                 107

5.17         TRADE DATA ANALYSIS                110

5.17.1      IMPORT DATA, 2019−2023            110

5.17.2      EXPORT DATA, 2019−2023            111

6               GENE EDITING MARKET, BY OFFERING 112

6.1           INTRODUCTION              113

6.2           PRODUCTS         113

6.2.1        EXPANDING APPLICATIONS OF GENE MODIFICATION TECHNIQUES TO

DRIVE MARKET 113

6.3           SERVICES             117

6.3.1        HIGH UPTAKE BY PHARMA COMPANIES FOR DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET       117

7               GENE EDITING PRODUCTS MARKET, BY TYPE   121

7.1           INTRODUCTION              122

7.2           REAGENTS & CONSUMABLES     122

7.2.1        GENE EDITING KITS       126

7.2.1.1    Increasing demand for mutation & screening kits in

clinical settings to propel market       126

7.2.2        GENE EDITING LIBRARIES           130

7.2.2.1    Genetic screening for cancer research to fuel uptake     130

7.2.3        GENE EDITING REAGENTS          133

7.2.3.1    Ability to create animal models to support market growth                 133

7.3           SOFTWARE & SYSTEMS 137

7.3.1        INTEGRATION OF CLOUD-BASED PLATFORMS FOR NGS TO DRIVE MARKET         137

8               GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE 141

8.1           INTRODUCTION              142

8.2           KNOCK-OUT      142

8.2.1        MODIFICATION OF CRISPR-CAS9 AND TALENS TO PROPEL MARKET             142

8.3           KNOCK-IN           146

8.3.1        UTILIZATION OF DONOR DNA TEMPLATES AND HDR PATHWAYS TO

DRIVE MARKET 146

8.4           GENE SILENCING             149

8.4.1        ADVANCEMENTS IN RNAI TECHNOLOGY AND ANTISENSE THERAPY TO SUPPORT MARKET GROWTH 149

8.5           OTHER TECHNIQUES    153

9               GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY                 156

9.1           INTRODUCTION              157

9.2           CRISPR 157

9.2.1        ADVANCEMENTS IN CAS9 PROTEINS TO FUEL UPTAKE                 157

9.3           TALENS                161

9.3.1        INCREASING DEMAND FOR THERAPEUTIC DEVELOPMENT TO DRIVE MARKET        161

9.4           ZFN        164

9.4.1        PROVISION OF CUSTOMIZED DESIGN AND TARGETED EDITS TO

BOOST DEMAND             164

9.5           BASE EDITING  167

9.5.1        GROWING APPLICATIONS IN FUNCTIONAL GENOMICS TO FUEL MARKET            167

9.6           ANTISENSE         171

9.6.1        INNOVATIONS IN OLIGONUCLEOTIDE THERAPIES TO SUPPORT MARKET GROWTH     171

9.7           RNAI      174

9.7.1        WIDE APPLICATIONS IN DRUG DISCOVERY TO FUEL UPTAKE                174

9.8           OTHER TECHNOLOGIES               177

10            GENE EDITING PRODUCTS MARKET, BY APPLICATION                 180

10.1         INTRODUCTION              181

10.2         CELL LINE ENGINEERING            181

10.2.1      ABILITY TO PROVIDE PRECISE GENE MODIFICATIONS FOR VALIDATION

TO DRIVE MARKET         181

10.3         GENOME EDITING          185

10.3.1      GROWING APPLICATIONS IN BIOTECHNOLOGY TO BOOST DEMAND             185

10.4         DRUG DISCOVERY & DEVELOPMENT     188

10.4.1      UPTAKE OF CRISPR-BASED SYSTEMS FOR DISEASE PROFILING TO

DRIVE MARKET 188

10.5         OTHER APPLICATIONS 192

11            GENE EDITING PRODUCTS MARKET, BY END USER                 195

11.1         INTRODUCTION              196

11.2         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 196

11.2.1      INCREASING PRODUCT APPROVALS AND ROBUST CLINICAL

PIPELINE TO PROPEL MARKET 196

11.3         ACADEMIC & RESEARCH INSTITUTES    200

11.3.1      FAVORABLE FUNDING FOR GENOMIC PROJECTS TO DRIVE MARKET 200

11.4         CROS & CDMOS                 203

11.4.1      PROVISION OF SPECIALIZED EXPERTISE FOR CLINICAL TRIALS TO

DRIVE MARKET 203

11.5         OTHER END USERS         206

12            GENE EDITING SERVICES MARKET, BY TYPE       210

12.1         INTRODUCTION              211

12.2         CELL LINE DEVELOPMENT & ENGINEERING      211

12.2.1      GROWING DEMAND FOR BIOLOGICS AND BIOSIMILARS TO DRIVE MARKET         211

12.3         GRNA SYNTHESIS & VECTOR CONSTRUCTION  215

12.3.1      ADVANCEMENTS IN GENE EDITING TECHNOLOGIES AND DEMAND FOR PRECISE TARGETING TO DRIVE MARKET                 215

12.4         LIBRARY CONSTRUCTION & SCREENING              218

12.4.1      INCREASING FOCUS ON HIGH-THROUGHPUT SCREENING TO PROPEL MARKET             218

12.5         OTHER SERVICES             222

12.5.1      OTHER SERVICES INCLUDE OFF-TARGET ANALYSIS AND MUTAGENESIS SERVICES. 222

13            GENE EDITING SERVICES MARKET, BY APPLICATION                 226

13.1         INTRODUCTION              227

13.2         CELL LINE ENGINEERING            227

13.2.1      HIGH UPTAKE IN R&D FOR THERAPEUTIC BIOPRODUCTION TO DRIVE MARKET   227

13.3         GENOME EDITING          231

13.3.1      GROWING FOCUS ON SYNTHETIC GENOMICS TO BOOST DEMAND             231

13.4         DRUG DISCOVERY & DEVELOPMENT     234

13.4.1      GROWING DEMAND FOR PHARMACEUTICAL DEVELOPMENT TO FUEL UPTAKE           234

13.5         OTHER APPLICATIONS 238

14            GENE EDITING SERVICES MARKET, BY END USER                 242

14.1         INTRODUCTION              243

14.2         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 243

14.2.1      GROWING DEMAND FOR ADVANCED MODALITIES TO DRIVE MARKET 243

14.3         ACADEMIC & RESEARCH INSTITUTES    247

14.3.1      INCREASING FUNDING FOR GENOMIC PROJECTS TO PROPEL MARKET             247

14.4         OTHER END USERS         250

15            GENE EDITING MARKET, BY REGION     254

15.1         INTRODUCTION              255

15.2         NORTH AMERICA             256

15.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 261

15.2.2      US           262

15.2.2.1  Growing investments by government authorities and private players to drive market        262

15.2.3      CANADA               266

15.2.3.1  Rise in research & development initiatives for genomics and biotechnology to augment growth     266

15.3         EUROPE               271

15.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      276

15.3.2      GERMANY           278

15.3.2.1  Growing focus on promoting innovations in biotechnology sector to boost market     278

15.3.3      FRANCE                283

15.3.3.1  Ongoing clinical trials and advanced genomic research to

promote growth    283

15.3.4      UK          287

15.3.4.1  Growing focus on developing cell and gene therapy infrastructure to fuel market        287

15.3.5      ITALY    292

15.3.5.1  Increasing availability of research funds to expedite growth                 292

15.3.6      SPAIN    296

15.3.6.1  Booming biotechnology sector to contribute to market growth                 296

15.3.7      REST OF EUROPE             301

15.4         ASIA PACIFIC     306

15.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 311

15.4.2      CHINA  312

15.4.2.1  Increasing affordability of sequencing platforms and procedures to favor growth      312

15.4.3      JAPAN   316

15.4.3.1  Growing focus on cancer research to fuel market            316

15.4.4      INDIA    321

15.4.4.1  Increased awareness about therapeutic benefits of genome engineering to encourage growth      321

15.4.5      SOUTH KOREA  326

15.4.5.1  Rising inclination toward in vivo gene editing to stimulate growth                 326

15.4.6      AUSTRALIA         330

15.4.6.1  Favorable regulatory landscape to sustain growth           330

15.4.7      REST OF ASIA PACIFIC   335

15.5         LATIN AMERICA                339

15.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 344

15.5.2      BRAZIL 345

15.5.2.1  Supportive regulatory framework for biotechnology innovation to fuel market             345

15.5.3      REST OF LATIN AMERICA             349

15.6         MIDDLE EAST   353

15.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST                 354

15.6.2      GCC COUNTRIES              359

15.6.2.1  Kingdom of Saudi Arabia    364

15.6.2.1.1                Increasing establishment of biotech startups to

support market growth        364

15.6.2.2  United Arab Emirates (UAE)             368

15.6.2.2.1                Growing collaborations for genome sequencing to

drive market          368

15.6.2.3  Other GCC Countries          373

15.6.3      REST OF MIDDLE EAST 377

15.7         AFRICA 382

15.7.1      IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH              382

15.7.2      MACROECONOMIC OUTLOOK FOR AFRICA        386

16            COMPETITIVE LANDSCAPE         388

16.1         INTRODUCTION              388

16.2         KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021−2024                 388

16.3         REVENUE ANALYSIS, 2019−2023                 392

16.4         MARKET SHARE ANALYSIS, 2023                 394

16.4.1      RANKING OF KEY MARKET PLAYERS       395

16.5         COMPANY VALUATION AND FINANCIAL METRICS                 396

16.5.1      COMPANY VALUATION 396

16.5.2      FINANCIAL METRICS      396

16.6         BRAND/PRODUCT COMPARISON             397

16.6.1      THERMO FISHER SCIENTIFIC INC. (US) 397

16.6.2      MERCK KGAA (GERMANY)           397

16.6.3      GENSCRIPT (US)               398

16.6.4      AGILENT TECHNOLOGIES, INC. (US)      398

16.6.5      REVVITY, INC. (US)          398

16.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 398

16.7.1      STARS   398

16.7.2      EMERGING LEADERS     398

16.7.3      PERVASIVE PLAYERS      398

16.7.4      PARTICIPANTS 399

16.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         400

16.7.5.1  Company footprint               400

16.7.5.2  Product footprint  401

16.7.5.3  Service footprint   402

16.7.5.4  Technology footprint           403

16.7.5.5  Region footprint   405

16.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        406

16.8.1      PROGRESSIVE COMPANIES         406

16.8.2      RESPONSIVE COMPANIES            406

16.8.3      DYNAMIC COMPANIES  406

16.8.4      STARTING BLOCKS         406

16.8.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 408

16.8.5.1  Detailed list of key startups/SMEs    408

16.8.5.2  Competitive benchmarking of key startups/SMEs          409

16.9         COMPETITIVE SCENARIO             409

16.9.1      PRODUCT/SERVICE LAUNCHES & APPROVALS  410

16.9.2      DEALS  411

16.9.3      EXPANSIONS     413

17            COMPANY PROFILES      414

17.1         KEY PLAYERS     414

17.1.1      THERMO FISHER SCIENTIFIC INC.            414

17.1.1.1  Business overview 414

17.1.1.2  Products/Services offered   415

17.1.1.3  Recent developments           417

17.1.1.3.1                Product/Service launches & approvals              417

17.1.1.3.2                Deals      417

17.1.1.3.3                Expansions             418

17.1.1.4  MnM view              418

17.1.1.4.1                Key strengths        418

17.1.1.4.2                Strategic choices   418

17.1.1.4.3                Weaknesses & competitive threats     418

17.1.2      MERCK KGAA    419

17.1.2.1  Business overview 419

17.1.2.2  Products/Services offered   420

17.1.2.3  Recent developments           422

17.1.2.3.1                Deals      422

17.1.2.4  MnM view              422

17.1.2.4.1                Key strengths        422

17.1.2.4.2                Strategic choices   422

17.1.2.4.3                Weaknesses & competitive threats     423

17.1.3      GENSCRIPT        424

17.1.3.1  Business overview 424

17.1.3.2  Products/Services offered   425

17.1.3.3  Recent developments           427

17.1.3.3.1                Product/Service launches & approvals              427

17.1.3.3.2                Deals      428

17.1.3.3.3                Expansions             428

17.1.3.4  MnM view              428

17.1.3.4.1                Key strengths        428

17.1.3.4.2                Strategic choices   429

17.1.3.4.3                Weaknesses and competitive threats 429

17.1.4      AGILENT TECHNOLOGIES, INC.                430

17.1.4.1  Business overview 430

17.1.4.2  Products/Services offered   431

17.1.4.3  Recent developments           433

17.1.4.3.1                Deals      433

17.1.4.3.2                Expansions             434

17.1.4.4  MnM view              434

17.1.4.4.1                Key strengths        434

17.1.4.4.2                Strategic choices   434

17.1.4.4.3                Weaknesses & competitive threats     434

17.1.5      REVVITY, INC.   435

17.1.5.1  Business overview 435

17.1.5.2  Products/Services offered   436

17.1.5.3  Recent developments           439

17.1.5.3.1                Product/Service launches   439

17.1.5.3.2                Deals      439

17.1.5.4  MnM view              440

17.1.5.4.1                Key strengths        440

17.1.5.4.2                Strategic choices   440

17.1.5.4.3                Weakness & competitive threats        440

17.1.6      LONZA 441

17.1.6.1  Business overview 441

17.1.6.2  Products/Services offered   442

17.1.6.3  Recent developments           443

17.1.6.3.1                Product/Service launches   443

17.1.7      TECAN TRADING AG      444

17.1.7.1  Business overview 444

17.1.7.2  Products/Services offered   445

17.1.7.3  Recent developments           446

17.1.7.3.1 Deals    446

17.1.8      SANGAMO THERAPEUTICS         447

17.1.8.1  Business overview 447

17.1.8.2  Products/Services offered   448

17.1.8.3  Recent developments           448

17.1.8.3.1                Deals      448

17.1.9      PRECISION BIOSCIENCES             449

17.1.9.1  Business overview 449

17.1.9.2  Products/Services offered   450

17.1.9.3  Recent developments           450

17.1.9.3.1                Deals      450

17.1.10   CELLECTIS S.A. 451

17.1.10.1                 Business overview 451

17.1.10.2                 Products/Services offered   452

17.1.10.3                 Recent developments           452

17.1.10.3.1             Deals      452

17.1.11   REGENERON PHARMACEUTICALS, INC. 453

17.1.11.1                 Business overview 453

17.1.11.2                 Products/Services offered   454

17.1.11.3                 Recent developments           454

17.1.11.3.1             Deals      454

17.1.12   AMSBIO                455

17.1.12.1                 Business overview 455

17.1.12.2                 Products/Services offered   455

17.1.13   CREATIVE BIOGENE       457

17.1.13.1                 Business overview 457

17.1.13.2                 Products/Services offered   457

17.1.14   SYNTHEGO         460

17.1.14.1                 Business overview 460

17.1.14.2                 Products/Services offered   460

17.1.14.3                 Recent developments           462

17.1.14.3.1             Product/Service launches   462

17.1.14.3.2             Deals      462

17.1.14.3.3             Expansions             462

17.1.15   TAKARA BIO INC.             463

17.1.15.1                 Business overview 463

17.1.15.2                 Products/Services offered   464

17.1.15.3                 Recent developments           466

17.1.15.3.1             Deals      466

17.1.15.3.2             Expansions             466

17.1.16   BIO-TECHNE     467

17.1.16.1                 Business overview 467

17.1.16.2                 Products/Services offered   468

17.1.16.3                 Recent developments           470

17.1.16.3.1             Deals      470

17.1.16.3.2             Expansions             470

17.1.17   CARIBOU BIOSCIENCES, INC.     471

17.1.17.1                 Business overview 471

17.1.17.2                 Products/Services offered   472

17.1.17.3                 Recent developments           472

17.1.17.3.1             Deals      472

17.1.18   BIONEER CORPORATION             473

17.1.18.1                 Business overview 473

17.1.18.2                 Products/Services offered   474

17.1.19   REPROCELL INC.              475

17.1.19.1                 Business overview 475

17.1.19.2                 Products/Services offered   476

17.2         OTHER PLAYERS              477

17.2.1      ALSTEM INC.      477

17.2.2      NEW ENGLAND BIOLABS              478

17.2.3      INSCRIPTA, INC.               479

17.2.4      BIOCAT GMBH. 480

17.2.5      INTEGRATED DNA TECHNOLOGIES, INC.             481

17.2.6      COBO TECHNOLOGIES APS        482

17.2.7      GENECOPOEIA, INC.       483

17.2.8      HERA BIOLABS 484

17.2.9      STEMCELL TECHNOLOGIES.      485

17.2.10   AXOL BIOSCIENCE LTD.                486

17.2.11   CELLECTA, INC.                487

17.2.12   APPLIED STEMCELL       488

18            APPENDIX           489

18.1         DISCUSSION GUIDE        489

18.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                494

18.3         CUSTOMIZATION OPTIONS        496

18.4         RELATED REPORTS         496

18.5         AUTHOR DETAILS           497

LIST OF TABLES

TABLE 1                IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS              56

TABLE 2                GENE EDITING MARKET: RISK ASSESSMENT ANALYSIS            59

TABLE 3                GENE EDITING MARKET: IMPACT ANALYSIS                 69

TABLE 4                APPROVALS FOR PERSONALIZED MEDICINE (GENE THERAPIES), 2023−2024  70

TABLE 5                PERSONALIZED MEDICINE APPROVALS (GENE THERAPIES) IN 2022        70

TABLE 6                AVERAGE COST RANGE OF GENE EDITING KITS & REAGENTS, 2021−2023                77

TABLE 7                AVERAGE SELLING PRICE, BY REGION, 2021−2023 (USD)              79

TABLE 8                COMMERCIALIZATION OF AI IN GENE EDITING                 87

TABLE 9                GENE EDITING MARKET: KEY CONFERENCES & EVENTS, 2024–2025           94

TABLE 10              NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  100

TABLE 11              EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  100

TABLE 12              ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  101

TABLE 13              REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             102

TABLE 14              GENE EDITING MARKET: PORTER’S FIVE FORCES ANALYSIS           103

TABLE 15              GENE EDITING MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)          104

TABLE 16              INVESTMENT & FUNDING ACTIVITIES, BY KEY PLAYER (2021−2024)       107

TABLE 17              IMPORT DATA FOR KITS & REAGENTS, BY REGION, 2019−2023 (USD)           110

TABLE 18              EXPORT DATA FOR KITS & REAGENTS, BY REGION, 2019−2023 (USD THOUSAND) 111

TABLE 19              GENE EDITING MARKET, BY OFFERING, 2022–2029 (USD MILLION)       113

TABLE 20              GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)          114

TABLE 21              NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY REGION,

2022–2029 (USD MILLION)            114

TABLE 22              EUROPE: GENE EDITING PRODUCTS MARKET, BY REGION,

2022–2029 (USD MILLION)            115

TABLE 23              ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY REGION,

2022–2029 (USD MILLION)            115

TABLE 24              LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY REGION,

2022–2029 (USD MILLION)            116

TABLE 25              MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION,

2022–2029 (USD MILLION)            116

TABLE 26              GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY REGION,

2022–2029 (USD MILLION)            116

TABLE 27              GENE EDITING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)            117

TABLE 28              NORTH AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            118

TABLE 29              EUROPE: GENE EDITING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            118

TABLE 30              ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            119

TABLE 31              LATIN AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            119

TABLE 32              MIDDLE EAST: GENE EDITING SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            119

TABLE 33              GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            120

TABLE 34              GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)            122

TABLE 35              GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)            123

TABLE 36              GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)            123

TABLE 37              NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)       124

TABLE 38              EUROPE: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 124

TABLE 39              ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)       125

TABLE 40              LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)       125

TABLE 41              MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)       125

TABLE 42              GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)       126

TABLE 43              GENE EDITING KITS MARKET, BY REGION, 2022–2029 (USD MILLION)       127

TABLE 44             NORTH AMERICA: GENE EDITING KITS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            127

TABLE 45              EUROPE: GENE EDITING KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     128

TABLE 46              ASIA PACIFIC: GENE EDITING KITS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            128

TABLE 47              LATIN AMERICA: GENE EDITING KITS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            129

TABLE 48              MIDDLE EAST: GENE EDITING KITS MARKET, BY REGION,

2022–2029 (USD MILLION)            129

TABLE 49              GCC COUNTRIES: GENE EDITING KITS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            129

TABLE 50              GENE EDITING LIBRARIES MARKET, BY REGION, 2022–2029 (USD MILLION)            130

TABLE 51              NORTH AMERICA: GENE EDITING LIBRARIES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            131

TABLE 52              EUROPE: GENE EDITING LIBRARIES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            131

TABLE 53              ASIA PACIFIC: GENE EDITING LIBRARIES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            132

TABLE 54              LATIN AMERICA: GENE EDITING LIBRARIES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            132

TABLE 55              MIDDLE EAST: GENE EDITING LIBRARIES MARKET, BY REGION,

2022–2029 (USD MILLION)            132

TABLE 56              GCC COUNTRIES: GENE EDITING LIBRARIES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            133

TABLE 57             GENE EDITING REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)            134

TABLE 58              NORTH AMERICA: GENE EDITING REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            134

TABLE 59              EUROPE: GENE EDITING REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            135

TABLE 60              ASIA PACIFIC: GENE EDITING REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            135

TABLE 61              LATIN AMERICA: GENE EDITING REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            136

TABLE 62              MIDDLE EAST: GENE EDITING REAGENTS MARKET, BY REGION,

2022–2029 (USD MILLION)            136

TABLE 63              GCC COUNTRIES: GENE EDITING REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            136

TABLE 64              GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY REGION, 2022–2029 (USD MILLION)                 137

TABLE 65              NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 138

TABLE 66              EUROPE: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS,

BY COUNTRY, 2022–2029 (USD MILLION)               138

TABLE 67              ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS,

BY COUNTRY, 2022–2029 (USD MILLION)               139

TABLE 68              LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 139

TABLE 69              MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS,

BY REGION, 2022–2029 (USD MILLION)   139

TABLE 70              GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 140

TABLE 71              GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE,

2022–2029 (USD MILLION)            142

TABLE 72              KNOCK-OUT TECHNIQUE MARKET, BY REGION, 2022–2029 (USD MILLION)            143

TABLE 73              NORTH AMERICA: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            143

TABLE 74              EUROPE: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            144

TABLE 75              ASIA PACIFIC: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            144

TABLE 76              LATIN AMERICA: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            145

TABLE 77              MIDDLE EAST: KNOCK-OUT TECHNIQUE MARKET, BY REGION,

2022–2029 (USD MILLION)            145

TABLE 78              GCC COUNTRIES: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            145

TABLE 79              KNOCK-IN TECHNIQUE MARKET, BY REGION, 2022–2029 (USD MILLION)            146

TABLE 80              NORTH AMERICA: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            147

TABLE 81              EUROPE: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            147

TABLE 82              ASIA PACIFIC: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            148

TABLE 83              LATIN AMERICA: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            148

TABLE 84             MIDDLE EAST: KNOCK-IN TECHNIQUE MARKET, BY REGION,

2022–2029 (USD MILLION)            148

TABLE 85              GCC COUNTRIES: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            149

TABLE 86              GENE SILENCING TECHNIQUE MARKET, BY REGION,

2022–2029 (USD MILLION)            150

TABLE 87              NORTH AMERICA: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            150

TABLE 88              EUROPE: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            151

TABLE 89              ASIA PACIFIC: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            151

TABLE 90              LATIN AMERICA: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            152

TABLE 91              MIDDLE EAST: GENE SILENCING TECHNIQUE MARKET, BY REGION,

2022–2029 (USD MILLION)            152

TABLE 92              GCC COUNTRIES: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            152

TABLE 93              OTHER TECHNIQUES MARKET, BY REGION, 2022–2029 (USD MILLION)            153

TABLE 94              NORTH AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            153

TABLE 95              EUROPE: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     154

TABLE 96              ASIA PACIFIC: OTHER TECHNIQUES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            154

TABLE 97             LATIN AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            155

TABLE 98              MIDDLE EAST: OTHER TECHNIQUES MARKET, BY REGION,

2022–2029 (USD MILLION)            155

TABLE 99              GCC COUNTRIES: OTHER TECHNIQUES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            155

TABLE 100            GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            157

TABLE 101            GENE EDITING PRODUCTS MARKET FOR CRISPR, BY REGION,

2022–2029 (USD MILLION)            158

TABLE 102            NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022–2029 (USD MILLION)                 158

TABLE 103            EUROPE: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY,

2022–2029 (USD MILLION)            159

TABLE 104            ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022–2029 (USD MILLION)                 159

TABLE 105            LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022–2029 (USD MILLION)                 160

TABLE 106            MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY REGION, 2022–2029 (USD MILLION)                 160

TABLE 107            GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022–2029 (USD MILLION)                 160

TABLE 108            GENE EDITING PRODUCTS MARKET FOR TALEN, BY REGION,

2022–2029 (USD MILLION)            161

TABLE 109            NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022–2029 (USD MILLION)                 162

TABLE 110            EUROPE: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY,

2022–2029 (USD MILLION)            162

TABLE 111            ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022–2029 (USD MILLION)                 163

TABLE 112            LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022–2029 (USD MILLION)                 163

TABLE 113            MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR TALEN, BY REGION,

2022–2029 (USD MILLION)            163

TABLE 114            GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022–2029 (USD MILLION)                 164

TABLE 115            GENE EDITING PRODUCTS MARKET FOR ZFN, BY REGION,

2022–2029 (USD MILLION)            164

TABLE 116            NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022–2029 (USD MILLION)                 165

TABLE 117            EUROPE: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY,

2022–2029 (USD MILLION)            165

TABLE 118            ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY,

2022–2029 (USD MILLION)            166

TABLE 119            LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022–2029 (USD MILLION)                 166

TABLE 120            MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ZFN, BY REGION,

2022–2029 (USD MILLION)            166

TABLE 121            GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022–2029 (USD MILLION)                 167

TABLE 122            GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY REGION,

2022–2029 (USD MILLION)            168

TABLE 123            NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR BASE EDITING,

BY COUNTRY, 2022–2029 (USD MILLION)               168

TABLE 124            EUROPE: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022–2029 (USD MILLION)                 169

TABLE 125            ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR BASE EDITING,

BY COUNTRY, 2022–2029 (USD MILLION)               169

TABLE 126            LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR BASE EDITING,

BY COUNTRY, 2022–2029 (USD MILLION)               170

TABLE 127            MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY REGION, 2022–2029 (USD MILLION)            170

TABLE 128            GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR BASE EDITING,

BY COUNTRY, 2022–2029 (USD MILLION)               170

TABLE 129            GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY REGION,

2022–2029 (USD MILLION)            171

TABLE 130            NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ANTISENSE,

BY COUNTRY, 2022–2029 (USD MILLION)               171

TABLE 131            EUROPE: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022–2029 (USD MILLION)                 172

TABLE 132            ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022–2029 (USD MILLION)            172

TABLE 133            LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ANTISENSE,

BY COUNTRY, 2022–2029 (USD MILLION)               173

TABLE 134            MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY REGION, 2022–2029 (USD MILLION)                 173

TABLE 135            GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ANTISENSE,

BY COUNTRY, 2022–2029 (USD MILLION)               173

TABLE 136            GENE EDITING PRODUCTS MARKET FOR RNAI, BY REGION,

2022–2029 (USD MILLION)            174

TABLE 137            NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022–2029 (USD MILLION)                 174

TABLE 138            EUROPE: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY,

2022–2029 (USD MILLION)            175

TABLE 139            ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY,

2022–2029 (USD MILLION)            175

TABLE 140            LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022–2029 (USD MILLION)                 176

TABLE 141            MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR RNAI, BY REGION,

2022–2029 (USD MILLION)            176

TABLE 142            GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022–2029 (USD MILLION)                 176

TABLE 143            GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)                 177

TABLE 144            NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION) 177

TABLE 145            EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES,

BY COUNTRY, 2022–2029 (USD MILLION)               178

TABLE 146            ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES,

BY COUNTRY, 2022–2029 (USD MILLION)               178

TABLE 147            LATIN AMERICA: GENE EDITING GENE EDITING PRODUCTS MARKET FOR

OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)            179

TABLE 148            MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES,

BY REGION, 2022–2029 (USD MILLION)   179

TABLE 149            GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION) 179

TABLE 150            GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              181

TABLE 151            CELL LINE ENGINEERING PRODUCTS MARKET, BY REGION,

2022–2029 (USD MILLION)            182

TABLE 152            NORTH AMERICA: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 182

TABLE 153            EUROPE: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            183

TABLE 154            ASIA PACIFIC: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            183

TABLE 155            LATIN AMERICA: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 184

TABLE 156            MIDDLE EAST: CELL LINE ENGINEERING PRODUCTS MARKET, BY REGION,

2022–2029 (USD MILLION)            184

TABLE 157            GCC COUNTRIES: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 184

TABLE 158            GENOME EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)          185

TABLE 159            NORTH AMERICA: GENOME EDITING PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            186

TABLE 160            EUROPE: GENOME EDITING PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            186

TABLE 161            ASIA PACIFIC: GENOME EDITING PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            187

TABLE 162            LATIN AMERICA: GENOME EDITING PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            187

TABLE 163            MIDDLE EAST: GENOME EDITING PRODUCTS MARKET, BY REGION,

2022–2029 (USD MILLION)            187

TABLE 164            GCC COUNTRIES: GENOME EDITING PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            188

TABLE 165            DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY REGION,

2022–2029 (USD MILLION)            189

TABLE 166            NORTH AMERICA: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               189

TABLE 167            EUROPE: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 190

TABLE 168            ASIA PACIFIC: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               190

TABLE 169            LATIN AMERICA: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               191

TABLE 170            MIDDLE EAST: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET,

BY REGION, 2022–2029 (USD MILLION)   191

TABLE 171            GCC COUNTRIES: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION) (USD MILLION)                 191

TABLE 172            GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)                 192

TABLE 173            NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 192

TABLE 174            EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               193

TABLE 175            ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               193

TABLE 176            LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 194

TABLE 177            MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS,

BY REGION, 2022–2029 (USD MILLION)   194

TABLE 178            GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 194

TABLE 179            GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)                196

TABLE 180            GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL &

BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)            197

TABLE 181            NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)   197

TABLE 182            EUROPE: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     198

TABLE 183            ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)   198

TABLE 184            LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)   199

TABLE 185            MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)        199

TABLE 186            GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)   199

TABLE 187            GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,

BY REGION, 2022–2029 (USD MILLION)   200

TABLE 188            NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)     200

TABLE 189            EUROPE: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)       201

TABLE 190            ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)     201

TABLE 191            LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)     202

TABLE 192            MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)            202

TABLE 193            GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)     202

TABLE 194            GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY REGION,

2022–2029 (USD MILLION)            203

TABLE 195            NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS,

BY COUNTRY, 2022–2029 (USD MILLION)               204

TABLE 196            EUROPE: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)                 204

TABLE 197            ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS,

BY COUNTRY, 2022–2029 (USD MILLION)               205

TABLE 198            LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS,

BY COUNTRY, 2022–2029 (USD MILLION)               205

TABLE 199            MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS,

BY REGION, 2022–2029 (USD MILLION)   205

TABLE 200            GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS,

BY COUNTRY, 2022–2029 (USD MILLION)               206

TABLE 201            GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY REGION,

2022–2029 (USD MILLION)            206

TABLE 202            NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)               207

TABLE 203            EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)               207

TABLE 204            ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)               208

TABLE 205            LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)               208

TABLE 206            MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS,

BY REGION, 2022–2029 (USD MILLION)   208

TABLE 207            GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)               209

TABLE 208            GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)            211

TABLE 209            CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)                 212

TABLE 210            NORTH AMERICA: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 212

TABLE 211            EUROPE: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               213

TABLE 212            ASIA PACIFIC: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               213

TABLE 213            LATIN AMERICA: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 214

TABLE 214            MIDDLE EAST: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET,

BY REGION, 2022–2029 (USD MILLION)   214

TABLE 215            GCC COUNTRIES: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 214

TABLE 216            GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)                 215

TABLE 217            NORTH AMERICA: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 216

TABLE 218            EUROPE: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               216

TABLE 219            ASIA PACIFIC: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               217

TABLE 220            LATIN AMERICA: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 217

TABLE 221            MIDDLE EAST: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 217

TABLE 222            GCC COUNTRIES: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 218

TABLE 223            LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            219

TABLE 224            NORTH AMERICA: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               219

TABLE 225            EUROPE: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               220

TABLE 226            ASIA PACIFIC: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               220

TABLE 227            LATIN AMERICA: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               221

TABLE 228            MIDDLE EAST: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET,

BY REGION, 2022–2029 (USD MILLION)   221

TABLE 229            GCC COUNTRIES: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET,

BY REGION, 2022–2029 (USD MILLION)   221

TABLE 230            GENE EDITING MARKET FOR OTHER SERVICES, BY REGION,

2022–2029 (USD MILLION)            222

TABLE 231            NORTH AMERICA: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)                 223

TABLE 232            EUROPE: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY,

2022–2029 (USD MILLION)            223

TABLE 233            ASIA PACIFIC: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY,

2022–2029 (USD MILLION)            224

TABLE 234            LATIN AMERICA: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)                 224

TABLE 235            MIDDLE EAST: GENE EDITING MARKET FOR OTHER SERVICES, BY REGION,

2022–2029 (USD MILLION)            224

TABLE 236            GCC COUNTRIES: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)                 225

TABLE 237            GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              227

TABLE 238            CELL ENGINEERING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)          228

TABLE 239            NORTH AMERICA: CELL ENGINEERING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            228

TABLE 240            EUROPE: CELL ENGINEERING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            229

TABLE 241            ASIA PACIFIC: CELL ENGINEERING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            229

TABLE 242            LATIN AMERICA: CELL ENGINEERING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            230

TABLE 243            MIDDLE EAST: CELL ENGINEERING SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            230

TABLE 244            GCC COUNTRIES: CELL ENGINEERING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            230

TABLE 245            GENOME EDITING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)          231

TABLE 246            NORTH AMERICA: GENOME EDITING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            232

TABLE 247            EUROPE: GENOME EDITING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            232

TABLE 248            ASIA PACIFIC: GENOME EDITING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            233

TABLE 249            LATIN AMERICA: GENOME EDITING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            233

TABLE 250            MIDDLE EAST: GENOME EDITING SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            233

TABLE 251            GCC COUNTRIES: GENOME EDITING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            234

TABLE 252            DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            235

TABLE 253            NORTH AMERICA: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET,

BY REGION, 2022–2029 (USD MILLION)   235

TABLE 254            EUROPE: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)                 236

TABLE 255            ASIA PACIFIC: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               236

TABLE 256            LATIN AMERICA: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               237

TABLE 257            MIDDLE EAST: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET,

BY REGION, 2022–2029 (USD MILLION)   237

TABLE 258            GCC COUNTRIES: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               237

TABLE 259            GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION,

2022–2029 (USD MILLION)            238

TABLE 260            NORTH AMERICA: GENE EDITING SERVICES MARKET FOR

OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            239

TABLE 261            EUROPE: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               239

TABLE 262            ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               240

TABLE 263            LATIN AMERICA: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               240

TABLE 264            MIDDLE EAST: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS,

BY REGION, 2022–2029 (USD MILLION)   240

TABLE 265            GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR

OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            241

TABLE 266            GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)                243

TABLE 267            GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL &

BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)            244

TABLE 268            NORTH AMERICA: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL

& BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)            244

TABLE 269            EUROPE: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     245

TABLE 270            ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)   245

TABLE 271            LATIN AMERICA: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)   246

TABLE 272            MIDDLE EAST: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)        246

TABLE 273            GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)   246

TABLE 274            GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES,

BY REGION, 2022–2029 (USD MILLION)   247

TABLE 275            NORTH AMERICA: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)     248

TABLE 276            EUROPE: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)       248

TABLE 277            ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)            249

TABLE 278            LATIN AMERICA: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)            249

TABLE 279            MIDDLE EAST: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)            249

TABLE 280            GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)     250

TABLE 281            GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY REGION,

2022–2029 (USD MILLION)            251

TABLE 282            NORTH AMERICA: GENE EDITING SERVICES MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)               251

TABLE 283            EUROPE: GENE EDITING SERVICES MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)               252

TABLE 284            ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)               252

TABLE 285            LATIN AMERICA: GENE EDITING SERVICES MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)               253

TABLE 286            MIDDLE EAST: GENE EDITING SERVICES MARKET FOR OTHER END USERS,

BY REGION, 2022–2029 (USD MILLION)   253

TABLE 287            GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)               253

TABLE 288            GENE EDITING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)          255

TABLE 289            GENE EDITING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)            255

TABLE 290            NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            257

TABLE 291            NORTH AMERICA GENE EDITING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            257

TABLE 292            NORTH AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)                 257

TABLE 293            NORTH AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          258

TABLE 294            NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            258

TABLE 295            NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            259

TABLE 296            NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            259

TABLE 297            NORTH AMERICA: GENE EDITING SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            260

TABLE 298            NORTH AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            260

TABLE 299            NORTH AMERICA: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            261

TABLE 300            NORTH AMERICA: MACROECONOMIC INDICATORS      262

TABLE 301            US: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                263

TABLE 302            US: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            263

TABLE 303            US: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE,

2022–2029 (USD MILLION)            263

TABLE 304            US: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            264

TABLE 305            US: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            264

TABLE 306            US: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            265

TABLE 307            US: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)            265

TABLE 308            US: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            266

TABLE 309            US: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)                266

TABLE 310            CANADA: GENE EDITING PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            267

TABLE 311            CANADA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            267

TABLE 312            CANADA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)            268

TABLE 313            CANADA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            268

TABLE 314            CANADA: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            269

TABLE 315            CANADA: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            269

TABLE 316            CANADA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                270

TABLE 317            CANADA: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            270

TABLE 318            CANADA: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            271

TABLE 319            EUROPE: GENE EDITING PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            272

TABLE 320            EUROPE: GENE EDITING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            272

TABLE 321            EUROPE: GENE EDITING PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            273

TABLE 322            EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            273

TABLE 323            EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)            273

TABLE 324            EUROPE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            274

TABLE 325            EUROPE: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            274

TABLE 326            EUROPE: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            275

TABLE 327            EUROPE: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                275

TABLE 328            EUROPE: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            276

TABLE 329            EUROPE: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            276

TABLE 330            EUROPE: MACROECONOMIC INDICATORS                 277

TABLE 331          GERMANY: GENE EDITING PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            278

TABLE 332            GERMANY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            279

TABLE 333            GERMANY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)            279

TABLE 334          GERMANY: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            280

TABLE 335          GERMANY: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            280

TABLE 336          GERMANY: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            281

TABLE 337            GERMANY: GENE EDITING SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            281

TABLE 338            GERMANY: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            282

TABLE 339            GERMANY: GENE EDITING SERVICES MARKET, BY END USERS,

2022–2029 (USD MILLION)            282

TABLE 340            FRANCE: GENE EDITING PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            283

TABLE 341            FRANCE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            284

TABLE 342            FRANCE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)            284

TABLE 343            FRANCE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            285

TABLE 344            FRANCE: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            285

TABLE 345            FRANCE: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            286

TABLE 346            FRANCE: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                286

TABLE 347            FRANCE: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            287

TABLE 348            FRANCE: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            287

TABLE 349            UK: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                288

TABLE 350            UK: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            288

TABLE 351            UK: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE,

2022–2029 (USD MILLION)            289

TABLE 352            UK: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            289

TABLE 353            UK: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            290

TABLE 354            UK: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            290

TABLE 355          UK: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)            291

TABLE 356            UK: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            291

TABLE 357            UK: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)                292

TABLE 358            ITALY: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                293

TABLE 359            ITALY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            293

TABLE 360            ITALY: GENE EDITING REAGENTS & CONSUMABLES MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          293

TABLE 361            ITALY: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            294

TABLE 362            ITALY: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            294

TABLE 363            ITALY: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            295

TABLE 364            ITALY: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                295

TABLE 365            ITALY: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            296

TABLE 366            ITALY: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            296

TABLE 367            SPAIN: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                297

TABLE 368            SPAIN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            297

TABLE 369            SPAIN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)            298

TABLE 370            SPAIN: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            298

TABLE 371            SPAIN: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            299

TABLE 372            SPAIN: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            299

TABLE 373            SPAIN: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                300

TABLE 374            SPAIN: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            300

TABLE 375            SPAIN: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            301

TABLE 376            REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            302

TABLE 377            REST OF EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)                 302

TABLE 378            REST OF EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          302

TABLE 379            REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            303

TABLE 380            REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            303

TABLE 381            REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            304

TABLE 382            REST OF EUROPE: GENE EDITING SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            304

TABLE 383            REST OF EUROPE: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            305

TABLE 384            REST OF EUROPE: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            305

TABLE 385            ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            307

TABLE 386            ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            307

TABLE 387            ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            308

TABLE 388            ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)                 308

TABLE 389            ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          308

TABLE 390            ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            309

TABLE 391            ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            309

TABLE 392            ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            310

TABLE 393            ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            310

TABLE 394            ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            311

TABLE 395            ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            311

TABLE 396            ASIA PACIFIC: MACROECONOMIC INDICATORS                 312

TABLE 397            CHINA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                313

TABLE 398            CHINA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            313

TABLE 399            CHINA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)            313

TABLE 400            CHINA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            314

TABLE 401            CHINA: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            314

TABLE 402            CHINA: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            315

TABLE 403            CHINA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                315

TABLE 404            CHINA: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            316

TABLE 405            CHINA: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            316

TABLE 406            JAPAN: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                317

TABLE 407            JAPAN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            318

TABLE 408            JAPAN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)            318

TABLE 409            JAPAN: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            319

TABLE 410            JAPAN: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            319

TABLE 411            JAPAN: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            320

TABLE 412            JAPAN: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                320

TABLE 413            JAPAN: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            321

TABLE 414            JAPAN: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            321

TABLE 415            INDIA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                322

TABLE 416            INDIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            322

TABLE 417            INDIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)            323

TABLE 418            INDIA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            323

TABLE 419            INDIA: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            324

TABLE 420            INDIA: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            324

TABLE 421            INDIA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                325

TABLE 422            INDIA: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            325

TABLE 423            INDIA: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            326

TABLE 424            SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            326

TABLE 425            SOUTH KOREA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)                 327

TABLE 426            SOUTH KOREA: GENE EDITING REAGENTS & CONSUMABLES MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          327

TABLE 427            SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            328

TABLE 428            SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            328

TABLE 429            SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            329

TABLE 430            SOUTH KOREA: GENE EDITING SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            329

TABLE 431            SOUTH KOREA: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            330

TABLE 432            SOUTH KOREA: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            330

TABLE 433            AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            331

TABLE 434            AUSTRALIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)                 331

TABLE 435            AUSTRALIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)            332

TABLE 436            AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            332

TABLE 437            AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            333

TABLE 438            AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            333

TABLE 439            AUSTRALIA: GENE EDITING SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            334

TABLE 440            AUSTRALIA: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            334

TABLE 441            AUSTRALIA: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            335

TABLE 442            REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            335

TABLE 443            REST OF ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         336

TABLE 444            REST OF ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          336

TABLE 445            REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            337

TABLE 446            REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)            337

TABLE 447            REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            338

TABLE 448            REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            338

TABLE 449            REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            339

TABLE 450            REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            339

TABLE 451            LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            340

TABLE 452            LATIN AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            340

TABLE 453            LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            341

TABLE 454            LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)                 341

TABLE 455            LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          341

TABLE 456            LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            342

TABLE 457            LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            342

TABLE 458            LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            343

TABLE 459            LATIN AMERICA: GENE EDITING SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            343

TABLE 460            LATIN AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            344

TABLE 461            LATIN AMERICA: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            344

TABLE 462            LATIN AMERICA: MACROECONOMIC INDICATORS      345

TABLE 463            BRAZIL: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)         346

TABLE 464            BRAZIL: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            346

TABLE 465            BRAZIL: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)            346

TABLE 466            BRAZIL: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            347

TABLE 467            BRAZIL: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            347

TABLE 468            BRAZIL: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            348

TABLE 469            BRAZIL: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                348

TABLE 470            BRAZIL: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            349

TABLE 471            BRAZIL: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            349

TABLE 472            REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            350

TABLE 473            REST OF LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)            350

TABLE 474            REST OF LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)       350

TABLE 475            REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            351

TABLE 476            REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)            351

TABLE 477            REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)                 352

TABLE 478            REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            352

TABLE 479            REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)                 353

TABLE 480            REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)                 353

TABLE 481            MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION,

2022–2029 (USD MILLION)            354

TABLE 482            MIDDLE EAST: GENE EDITING SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            354

TABLE 483            MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            355

TABLE 484            MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)                 355

TABLE 485            MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          355

TABLE 486            MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            356

TABLE 487            MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            356

TABLE 488            MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            357

TABLE 489            MIDDLE EAST: GENE EDITING SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            357

TABLE 490            MIDDLE EAST: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            358

TABLE 491            MIDDLE EAST: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            358

TABLE 492            MIDDLE EAST: MACROECONOMIC INDICATORS                 359

TABLE 493            GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            359

TABLE 494            GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            360

TABLE 495            GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            360

TABLE 496            GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)                 360

TABLE 497            GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          361

TABLE 498            GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            361

TABLE 499            GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            362

TABLE 500            GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            362

TABLE 501            GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            363

TABLE 502            GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            363

TABLE 503            GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            364

TABLE 504            KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            365

TABLE 505            KINGDOM OF SAUDI ARABIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)            365

TABLE 506            KINGDOM OF SAUDI ARABIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)       365

TABLE 507            KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET,

BY TECHNOLOGY, 2022–2029 (USD MILLION)     366

TABLE 508            KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)            366

TABLE 509            KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)                 367

TABLE 510            KINGDOM OF SAUDI ARABIA: GENE EDITING SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            367

TABLE 511            KINGDOM OF SAUDI ARABIA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)                 368

TABLE 512            KINGDOM OF SAUDI ARABIA: GENE EDITING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)                 368

TABLE 513            UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            369

TABLE 514            UNITED ARAB EMIRATES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)            369

TABLE 515            UNITED ARAB EMIRATES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)       370

TABLE 516            UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            370

TABLE 517            UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)            371

TABLE 518            UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)                 371

TABLE 519            UNITED ARAB EMIRATES: GENE EDITING SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            372

TABLE 520            UNITED ARAB EMIRATES: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)                 372

TABLE 521            UNITED ARAB EMIRATES: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            373

TABLE 522            OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            374

TABLE 523            OTHER GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         374

TABLE 524            OTHER GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          374

TABLE 525            OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            375

TABLE 526            OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)            375

TABLE 527            OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)                 376

TABLE 528            OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            376

TABLE 529            OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)                 377

TABLE 530            OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            377

TABLE 531            REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            378

TABLE 532            REST OF MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         378

TABLE 533            REST OF MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          379

TABLE 534            REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            379

TABLE 535            REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)            380

TABLE 536            REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            380

TABLE 537            REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            381

TABLE 538            REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)                 381

TABLE 539            REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            382

TABLE 540            AFRICA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)         383

TABLE 541            AFRICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)            383

TABLE 542            AFRICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)            383

TABLE 543            AFRICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            384

TABLE 544            AFRICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            384

TABLE 545            AFRICA: GENE EDITING PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            385

TABLE 546            AFRICA: GENE EDITING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                385

TABLE 547            AFRICA: GENE EDITING SERVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            386

TABLE 548            AFRICA: GENE EDITING SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            386

TABLE 549            MACROECONOMIC OUTLOOK FOR AFRICA                 387

TABLE 550            GENE EDITING MARKET: OVERVIEW OF STRATEGIES ADOPTED

BY KEY PLAYERS, 2021−2024        388

TABLE 551            GENE EDITING MARKET: DEGREE OF COMPETITION, 2023       395

TABLE 552            GENE EDITING MARKET: PRODUCT FOOTPRINT       401

TABLE 553            GENE EDITING MARKET: SERVICE FOOTPRINT                 402

TABLE 554            GENE EDITING MARKET: TECHNOLOGY FOOTPRINT       403

TABLE 555            GENE EDITING MARKET: APPLICATION FOOTPRINT       404

TABLE 556            GENE EDITING MARKET: REGION FOOTPRINT                 405

TABLE 557            GENE EDITING MARKET: KEY STARTUPS/SMES                 408

TABLE 558            GENE EDITING MARKET: COMPETITIVE BENCHMARKING OF KEY START UPS/SMES         409

TABLE 559            GENE EDITING MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS,

JANUARY 2021–SEPTEMBER 2024                410

TABLE 560            GENE EDITING MARKET: DEALS, JANUARY 2021–SEPTEMBER 2024              411

TABLE 561            GENE EDITING MARKET: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024                413

TABLE 562            THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW          414

TABLE 563            THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED               415

TABLE 564            THERMO FISHER SCIENTIFIC INC.: PRODUCT APPROVALS/LAUNCHES, JANUARY 2021−SEPTEMBER 2024                 417

TABLE 565            THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–SEPTEMBER 2024                417

TABLE 566          THERMO FISHER SCIENTIFIC INC.: EXPANSIONS,

JANUARY 2021–SEPTEMBER 2024                418

TABLE 567            MERCK KGAA: COMPANY OVERVIEW     419

TABLE 568            MERCK KGAA.: PRODUCTS/SERVICES OFFERED                 420

TABLE 569            MERCK KGAA: DEALS, JANUARY 2021–SEPTEMBER 2024              422

TABLE 570            GENSCRIPT: COMPANY OVERVIEW         424

TABLE 571            GENSCRIPT.: PRODUCTS/SERVICES OFFERED                 425

TABLE 572            GENSCRIPT: PRODUCT/SERVICE LAUNCHES & APPROVALS,

JANUARY 2021–SEPTEMBER 2024                427

TABLE 573            GENSCRIPT: DEALS, JANUARY 2021–SEPTEMBER 2024        428

TABLE 574            GENSCRIPT: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024              428

TABLE 575            AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW          430

TABLE 576            AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED               431

TABLE 577            AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024                433

TABLE 578            AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024                434

TABLE 579            REVVITY. INC. COMPANY OVERVIEW     435

TABLE 580            REVVITY, INC.: PRODUCTS/SERVICES OFFERED                 436

TABLE 581            REVIVTY, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024                439

TABLE 582            REVVITY, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024              439

TABLE 583            LONZA: COMPANY OVERVIEW  441

TABLE 584            LONZA: PRODUCTS/SERVICES OFFERED                 442

TABLE 585            LONZA: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024                443

TABLE 586            TECAN TRADING AG: COMPANY OVERVIEW                 444

TABLE 587            TECAN TRADING AG: PRODUCTS/SERVICES OFFERED             445

TABLE 588            TECAN TRADING AG: DEALS, JANUARY 2021–SEPTEMBER 2024              446

TABLE 589            SANGAMO THERAPEUTICS: COMPANY OVERVIEW          447

TABLE 590            SANGAMO THERAPEUTICS: PRODUCTS/SERVICES OFFERED               448

TABLE 591            SANGAMO THERAPEUTICS: DEALS, JANUARY 2021–SEPTEMBER 2024   448

TABLE 592            PRECISION BIOSCIENCES: COMPANY OVERVIEW          449

TABLE 593            PRECISION BIOSCIENCES: PRODUCTS/SERVICES OFFERED               450

TABLE 594            PRECISION BIOSCIENCES: DEALS, JANUARY 2021–SEPTEMBER 2024   450

TABLE 595            CELLECTIS S.A.: COMPANY OVERVIEW  451

TABLE 596            CELLECTIS S.A.: PRODUCTS/SERVICES OFFERED             452

TABLE 597            CELLECTIS S.A.: DEALS, JANUARY 2021–SEPTEMBER 2024              452

TABLE 598            REGENERON PHARMACEUTICALS, INC.: COMPANY OVERVIEW   453

TABLE 599            REGENERON PHARMACEUTICALS INC.: PRODUCTS/SERVICES OFFERED               454

TABLE 600            REGENERON PHARMACEUTICALS, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024                454

TABLE 601            AMSBIO: COMPANY OVERVIEW 455

TABLE 602            AMSBIO: PRODUCTS/SERVICES OFFERED                 455

TABLE 603            CREATIVE BIOGENE: COMPANY OVERVIEW                 457

TABLE 604            CREATIVE BIOGENE: PRODUCTS/SERVICES OFFERED             457

TABLE 605            SYNTHEGO: COMPANY OVERVIEW          460

TABLE 606            SYNTHEGO: PRODUCTS/SERVICES OFFERED                 460

TABLE 607            SYNTHEGO: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024                462

TABLE 608            SYNTHEGO: DEALS, JANUARY 2021–SEPTEMBER 2024        462

TABLE 609            SYNTHEGO: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024              462

TABLE 610            TAKARA BIO INC.: COMPANY OVERVIEW                 463

TABLE 611            TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED             464

TABLE 612            TAKARA BIO INC.: DEALS, JANUARY 2021–SEPTEMBER 2024              466

TABLE 613            TAKARA BIO, INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024              466

TABLE 614            BIO-TECHNE: COMPANY OVERVIEW      467

TABLE 615            BIO-TECHNE.: PRODUCTS/SERVICES OFFERED                 468

TABLE 616            BIO-TECHNE: DEALS, JANUARY 2021–SEPTEMBER 2024              470

TABLE 617            BIO-TECHNE: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024              470

TABLE 618            CARIBOU BIOSCIENCES, INC.: COMPANY OVERVIEW          471

TABLE 619            CARIBOU BIOSCIENCES, INC.: PRODUCTS/SERVICES OFFERED               472

TABLE 620            CARIBOU BIOSCIENCES, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024   472

TABLE 621            BIONEER CORPORATION: COMPANY OVERVIEW          473

TABLE 622            BIONEER CORPORATION: PRODUCTS/SERVICES OFFERED               474

TABLE 623            REPROCELL, INC.: COMPANY OVERVIEW                 475

TABLE 624            REPROCELL, INC.: PRODUCTS/SERVICES OFFERED             476

TABLE 625            ALSTEM INC.: COMPANY OVERVIEW      477

TABLE 626            NEW ENGLAND BIOLABS: COMPANY OVERVIEW                 478

TABLE 627            INSCRIPTA, INC.: COMPANY OVERVIEW                 479

TABLE 628            BIOCAT GMBH: COMPANY OVERVIEW  480

TABLE 629            INTEGRATED DNA TECHNOLOGIES, INC.: COMPANY OVERVIEW   481

TABLE 630            COBO TECHNOLOGIES APS.: COMPANY OVERVIEW          482

TABLE 631            GENECOPOEIA, INC.: COMPANY OVERVIEW                 483

TABLE 632            HERA BIOLABS: COMPANY OVERVIEW  484

TABLE 633            STEMCELL TECHNOLOGIES: COMPANY OVERVIEW          485

TABLE 634            AXOL BIOSCIENCE LTD.: COMPANY OVERVIEW                 486

TABLE 635            CELLECTA, INC.: COMPANY OVERVIEW 487

TABLE 636            APPLIED STEMCELL: COMPANY OVERVIEW                 488

LIST OF FIGURES

FIGURE 1              RESEARCH DESIGN         48

FIGURE 2              GENE EDITING MARKET: BREAKDOWN OF PRIMARIES          50

FIGURE 3              GENE EDITING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023  51

FIGURE 4              MARKET SIZE ESTIMATION: APPROACH 1

(COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023                 52

FIGURE 5              ILLUSTRATIVE EXAMPLE OF AGILENT TECHNOLOGIES, INC.:

REVENUE SHARE ANALYSIS (2023)            52

FIGURE 6              MARKET SIZE VALIDATION FROM PRIMARY SOURCES             53

FIGURE 7              MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH                54

FIGURE 8              GENE EDITING MARKET: CAGR PROJECTIONS                 55

FIGURE 9              DATA TRIANGULATION METHODOLOGY                 57

FIGURE 10            GENE EDITING MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)       60

FIGURE 11            GENE EDITING PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)      61

FIGURE 12            GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE,

2024 VS. 2029 (USD MILLION)      61

FIGURE 13            GENE EDITING PRODUCTS MARKET, BY APPLICATION,

2024 VS. 2029 (USD MILLION)      62

FIGURE 14            GENE EDITING PRODUCTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)         62

FIGURE 15            GENE EDITING SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)      63

FIGURE 16            GENE EDITING SERVICES MARKET, BY APPLICATION,

2024 VS. 2029 (USD MILLION)      63

FIGURE 17            GENE EDITING SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)         64

FIGURE 18            GEOGRAPHIC SNAPSHOT OF GENE EDITING MARKET               65

FIGURE 19            INCREASING DEMAND FOR PERSONALIZED MEDICINE AND EXPANDING APPLICATIONS OF GENE EDITING TO DRIVE MARKET         66

FIGURE 20            REAGENTS & CONSUMABLES SEGMENT TO ACCOUNT FOR

LARGEST MARKET SHARE IN US IN 2023                 67

FIGURE 21            CELL LINE ENGINEERING TO REGISTER HIGHEST GROWTH DURING

FORECAST PERIOD         67

FIGURE 22           GENE EDITING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          68

FIGURE 23            GOVERNMENT FUNDING FOR GENE EDITING PROJECTS,

2019−2023 (USD MILLION)          71

FIGURE 24            TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES           75

FIGURE 25            AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY CONSUMABLES (2023)         76

FIGURE 26            AVERAGE SELLING PRICE TREND OF SERVICES, BY TYPE               78

FIGURE 27            AVERAGE SELLING PRICE, BY REGION, 2023 (USD)    80

FIGURE 28            GENE EDITING MARKET: SUPPLY CHAIN ANALYSIS            82

FIGURE 29            GENE EDITING MARKET: VALUE CHAIN ANALYSIS            83

FIGURE 30            GENE EDITING MARKET: TRANSFECTION & SCREENING TO

ADD MAXIMUM VALUE TO WORKFLOW                85

FIGURE 31            GENE EDITING MARKET: ECOSYSTEM ANALYSIS                 86

FIGURE 32            IMPACT OF AI/GEN AI IN GENE EDITING MARKET               88

FIGURE 33            PATENT APPLICATIONS FOR GENE EDITING (JANUARY 2013–DECEMBER 2023)              93

FIGURE 34            GENE EDITING MARKET: PORTER’S FIVE FORCES ANALYSIS           102

FIGURE 35            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS              104

FIGURE 36            KEY BUYING CRITERIA OF END USERS, BY PRODUCT           105

FIGURE 37            KEY BUYING CRITERIA OF END USERS, BY SERVICES             105

FIGURE 38            NIH FUNDING FOR GENE EDITING PROJECTS                 109

FIGURE 39            NORTH AMERICA: GENE EDITING MARKET SNAPSHOT          256

FIGURE 40            ASIA PACIFIC: GENE EDITING MARKET SNAPSHOT          306

FIGURE 41            GENE EDITING MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2019−2023       393

FIGURE 42            MARKET SHARE ANALYSIS OF GENE EDITING MARKET, 2023    394

FIGURE 43            RANKING OF KEY PLAYERS IN GENE EDITING MARKET, 2023    395

FIGURE 44            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS                396

FIGURE 45            EV/EBITDA OF KEY PLAYERS      396

FIGURE 46            GENE EDITING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS            397

FIGURE 47            GENE EDITING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023         399

FIGURE 48            GENE EDITING MARKET: COMPANY FOOTPRINT       400

FIGURE 49            GENE EDITING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 407

FIGURE 50            THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)             415

FIGURE 51            MERCK KGAA: COMPANY SNAPSHOT (2023)                 420

FIGURE 52            GENSCRIPT: COMPANY SNAPSHOT (2023)                 425

FIGURE 53            AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)             431

FIGURE 54            REVVITY, INC.: COMPANY SNAPSHOT (2023)                 436

FIGURE 55            LONZA: COMPANY SNAPSHOT (2023)     442

FIGURE 56            TECAN TRADING AG: COMPANY SNAPSHOT (2023)    445

FIGURE 57            SANGAMO THERAPEUTICS: COMPANY SNAPSHOT (2023)             447

FIGURE 58            PRECISION BIOSCIENCES: COMPANY SNAPSHOT (2023)             449

FIGURE 59            CELLECTIS S.A.: COMPANY SNAPSHOT (2023)                 451

FIGURE 60            REGENERON PHARMACEUTICALS INC.: COMPANY SNAPSHOT (2023)      453

FIGURE 61            TAKARA BIO INC.: COMPANY SNAPSHOT (2023)                 464

FIGURE 62            BIO-TECHNE: COMPANY SNAPSHOT (2023)                 468

FIGURE 63            CARIBOU BIOSCIENCES, INC.: COMPANY SNAPSHOT (2023)             471

FIGURE 64            BIONEER CORPORATION: COMPANY SNAPSHOT (2023)             473

FIGURE 65            REPROCELL, INC.: COMPANY SNAPSHOT (2023)                 475

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧